98 related articles for article (PubMed ID: 810369)
21. Contraceptive and endometrial effects of medroxyprogesterone acetate.
Lee RA
Am J Obstet Gynecol; 1969 May; 104(1):130-3. PubMed ID: 5777697
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of ovulation during discontinuous intranasal luteinizing hormone-releasing hormone agonist dosing in combination with gestagen-induced bleeding.
Lemay A; Faure N; Labrie F; Fazekas AT
Fertil Steril; 1985 Jun; 43(6):868-77. PubMed ID: 3158551
[TBL] [Abstract][Full Text] [Related]
23. Effect of contraception on lactation.
Guiloff E; Ibarra-Polo A; Zañartu J; Toscanini C; Mischler TW; Gómez-Rogers C
Am J Obstet Gynecol; 1974 Jan; 118(1):42-5. PubMed ID: 4128673
[TBL] [Abstract][Full Text] [Related]
24. Treatment of seizures with medroxyprogesterone acetate: preliminary report.
Mattson RH; Cramer JA; Caldwell BV; Siconolfi BC
Neurology; 1984 Sep; 34(9):1255-8. PubMed ID: 6540415
[TBL] [Abstract][Full Text] [Related]
25. Hormonal evaluation of the intrauterine progesterone contraceptive system.
Bryand-Greenwood GD; Greenwood FC; Hale RW; Morishige WK
J Clin Endocrinol Metab; 1977 Apr; 44(4):721-7. PubMed ID: 849982
[TBL] [Abstract][Full Text] [Related]
26. [Sensitivity of pituitary gonadotropins to luliberin in women using intrauterine contraceptive devices].
Kononova ES; Beskrovnyĭ SV; Svechnikova FA
Akush Ginekol (Mosk); 1984 Aug; (8):60. PubMed ID: 6435469
[TBL] [Abstract][Full Text] [Related]
27. The secretion of human chorionic gonadotropin-like substance in women employing contraceptive measures.
Huang SC; Chen HC; Chen RJ; Hsieh CY; Wei PY; Ouyang PC
J Clin Endocrinol Metab; 1984 Apr; 58(4):646-53. PubMed ID: 6699130
[TBL] [Abstract][Full Text] [Related]
28. Serum-prolactin levels in lactating women using the Progestasert system.
Badraoui MH; Askalani H; Mahrous I; Osman MI; Bayad MA; Ibrahim II; Abdalla MI
Contracept Deliv Syst; 1981 Apr; 2(1):121-6. PubMed ID: 12336863
[TBL] [Abstract][Full Text] [Related]
29. Medroxyprogesterone acetate in human serum.
Mathrubutham M; Fotherby K
J Steroid Biochem; 1981 Aug; 14(8):783-6. PubMed ID: 6457936
[TBL] [Abstract][Full Text] [Related]
30. A double-blind placebo controlled trial of medroxyprogesterone acetate and cyproterone acetate with seven pedophiles.
Cooper AJ; Sandhu S; Losztyn S; Cernovsky Z
Can J Psychiatry; 1992 Dec; 37(10):687-93. PubMed ID: 1473073
[TBL] [Abstract][Full Text] [Related]
31. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
[TBL] [Abstract][Full Text] [Related]
32. A radioimmunoassay for serum medroxyprogesterone acetate.
Shrimanker K; Saxena BN; Fotherby K
J Steroid Biochem; 1978 Apr; 9(4):359-63. PubMed ID: 661315
[TBL] [Abstract][Full Text] [Related]
33. Basal and metoclopramide-stimulated prolactin (PRL) serum levels in users and non-users of a copper intrauterine device (TCu-380 IUD).
Parra A; Gabiño F; Ramírez A; Valencia H; Coria I; Espinosa de los Monteros A
Contraception; 1991 Nov; 44(5):541-7. PubMed ID: 1797468
[TBL] [Abstract][Full Text] [Related]
34. Hormone interference in metastatic breast cancer patients treated with medroxyprogesterone acetate at massive doses: preliminary results.
Sala G; Castegnaro E; Lenaz GR; Martoni A; Piana E; Pannuti F
IRCS J Med Sci; 1978 Apr; 6(4):129. PubMed ID: 12312055
[TBL] [Abstract][Full Text] [Related]
35. Contraceptive effect of varying dosages of progestogen in silastic vaginal rings.
Mishell DR; Lumkin ME
Fertil Steril; 1970 Feb; 21(2):99-103. PubMed ID: 5414562
[TBL] [Abstract][Full Text] [Related]
36. Growth hormone secretion in idiopathic precocious puberty: effect of medroxyprogesterone.
Kaplan S; Frasier SD; Costin G
J Pediatr; 1969 Jul; 75(1):133-8. PubMed ID: 5790396
[TBL] [Abstract][Full Text] [Related]
37. Depo Provera: still controversial.
Wren LM
Int Health News; 1988 Feb; 9(2):2-3, 8. PubMed ID: 12179873
[TBL] [Abstract][Full Text] [Related]
38. High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions.
van den Berg HW; Martin J; Lynch M
Br J Cancer; 1990 Apr; 61(4):504-7. PubMed ID: 2139575
[TBL] [Abstract][Full Text] [Related]
39. Estrogenic activity in women receiving an injectable progestogen for contraception.
Mishell DR; Kharma KM; Thorneycroft IH; Nakamura RM
Am J Obstet Gynecol; 1972 Jun; 113(3):372-6. PubMed ID: 4637029
[TBL] [Abstract][Full Text] [Related]
40. Long-term effect of a first pregnancy on the secretion of prolactin.
Musey VC; Collins DC; Musey PI; Martino-Saltzman D; Preedy JR
N Engl J Med; 1987 Jan; 316(5):229-34. PubMed ID: 3099198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
